Bioinorganic Chemistry and Applications
Volume 2014 (2014), Article ID 959203, 11 pages
http://dx.doi.org/10.1155/2014/959203

Research Article

Synthesis, Characterization, Semiempirical and Biological Activities of Organotin(IV) Carboxylates with 4-Piperidinecarboxylic Acid

Shabbir Hussain,¹ Saqib Ali,² Saira Shahzadi,² Saroj K. Sharma,³ Kushal Qanungo,³ and Muhammad Shahid⁴

¹Department of Chemistry, GC University, Faisalabad 38000, Pakistan
²Department of Chemistry, Quaid-i-Azam University, Islamabad 45320, Pakistan
³Department of Applied Sciences and Humanities, Faculty of Engineering and Technology, Mody Institute of Technology and Science, Deemed University, Lakshmangarh, Sikar, Rajasthan 332311, India
⁴Department of Chemistry and Biochemistry, University of Agriculture, Faisalabad 38000, Pakistan

Received 28 May 2014; Revised 31 August 2014; Accepted 14 September 2014; Published 13 October 2014

Academic Editor: Igor O. Fritsky

Copyright © 2014 Shabbir Hussain et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Organotin (IV) carboxylates with the general formulae R₂Sn(Cl)L [R = Me (1), n-Bu (2), Ph (3)] and R₃SnL [R = Me (4), Ph (5)] have been synthesized by the reaction of 4-piperidinecarboxylic acid (HL) with KOH and R₂SnCl₂ (R = Me, n-Bu, Ph)/R₃SnCl (R = Me, Ph) in methanol under stirring conditions. The metal ligand binding site, structure, and stability of complexes have been verified by FT-IR, (¹H, ¹³C) NMR, EI-MS technique, and semiempirical study. The FT-IR data indicate the bidentate chelating mode of the carboxylate ligand which is also confirmed by semiempirical study. In solution state, five and four coordinated geometry around tin was confirmed by NMR spectroscopy. The EI-MS data agreed well with the molecular structure of the complexes. Thermodynamic parameters and molecular descriptors were calculated by using semiempirical PM3 method. HOMO-LUMO calculations show that chlorodiorganotin complexes are more susceptible to nucleophilic attack as compared to triorganotin complexes. Computed negative heat of formation indicates that complexes 1–4 are thermodynamically stable. The organotin(IV) carboxylates displayed powerful antimicrobial activities against various strains of bacteria and fungi and their minimal inhibitory concentration were also evaluated. The complexes exhibited comparatively higher hemolytic activity as compared to free ligand.

1. Introduction

Organotin complexes are subject of great interest due to their structural diversities and broad range of applications in various fields [1]. Coordination of carboxylates to organotin residues offers the possibility of studying the variations of the coordination modes which include monodentate, chelate, or the more subtle bridging, which may give rise to oligomeric or polymeric structures [1, 2]. Organotin(IV) carboxylates have been used in silicone curing [3], formation of polyurethane [4], antifouling paints [5], and PVC stabilization [6]. Organotin(IV) carboxylates possess significant properties as antibacterial and antifungal agents and also as antitumor and anticancer drugs [7]. The antifungal, antibacterial, and antitumor activities of organotin(IV) carboxylates are essentially related to the number and nature of the organic groups attached to the central Sn atom [8]. In general, triorganotin(IV) compounds display better biological activity than their diorganotin and monoorganotin analogs. This has been attributed to their ability to bind proteins [9]. However, the role of the ligand, for the transportation of organotin(IV) moiety to the target area, where the organotin(IV) species perform its biocidal activity, cannot be ignored [10]. The synthesis of organotin complexes in research area is of increased interest for inorganic, pharmaceutical, and medicinal chemistry as an approach to the development of new drugs [11, 12].

Research on the structure of organotin(IV) carboxylates continues and, at the same time, some new applications of high importance are being discovered which are relevant to ecological medicinal applications. The increasing interest in the chemistry of organotin(IV) compounds has led to the extended studies on their reactions with different biomolecules [13].

On the other hand, organotin(IV) compounds have been tested for their in vitro activity against a large variety of tumor cell lines [14] and have been found to be as effective as or better than traditional heavy metal anticancer drugs such as cisplatin.

Keeping in view the great importance of organotin chemistry and in continuation of our previous work [15–17], we report here the synthesis, characterization, semiempirical study, and biological activities of organotin carboxylates with 4-piperidinecarboxylic acid.

2. Experimental

2.1. Materials and Methods

Dimethyltin dichloride, dibutyltin dichloride, diphenyltin dichloride, trimethyltin chloride, and triphenyltin chloride were purchased from Sigma-Aldrich (USA) and used without any purification. 4-Piperidinecarboxylic acid was purchased from Merck (Germany). AR grade solvents of Merck (methanol), Lab-scan (DMSO), and Riedel-de Haen (petroleum ether) origin were used. The solvents were dried before use by standard procedures [18]. The samples were taken in capillary tubes and melting points were measured by an electrochemical melting point apparatus Stuart SMP3 and are uncorrected. Infrared spectra were recorded by a Perkin-Elmer-1000 FTIR spectrophotometer in the range of 4000–250 cm⁻¹ as KBr/CsBr pellets. The ¹H and ¹³C NMR spectra were recorded by Bruker ARC 300 MHz-FT-NMR spectrometer. The percentage composition of C, H, and N was determined by using CHNS-932 Leco (USA). The complexes were modeled by MOPAC 2007 [19] program in gas phase using PM3 method [20, 21]. Selected parts of the complexes not containing the metal ion were preoptimised using molecular mechanics methods. Several cycles of energy minimization were carried for each of the complexes. Geometry was optimized using Eigen Vector following. The root mean square gradient for complexes was less than one. Self-consistent field was achieved in each case.

Antimicrobial activities of the ligand and complexes were tested against bacteria (Escherichia coli, Bacillus subtilis, Staphylococcus aureus, and Pasteurella multocida) and fungi (Alternaria alternata, Ganoderma lucidum, Penicillium notatum, Trichoderma harzianum, and Aspergillus niger) by disc diffusion method [22] and minimum inhibitory concentration (MIC) [23]. The activities were performed in an incubator (Sanyo, Germany) and sterilized in an autoclave (Omron, Japan). The minimum inhibitory concentration was determined in a Micro Quant apparatus (BioTek, USA). Streptomycin and fluconazole were used as standard drugs for antibacterial and antifungal screening tests, respectively. The in vitro hemolytic bioassay [24] of the complexes was reported with respect to the triton X-100 as positive control and PBS as negative control.

2.2. General Procedure for the Synthesis of Complexes 1–5

4-Piperidinecarboxylic acid (1 mmol) and KOH (1 mmol) were stirred together in methanol (50 mL) for 1 hr in a 100 mL round bottom flask at room temperature. Then, R₂SnCl₂/R₃SnCl (1 mmol) was added as solid in portions and reaction mixture was continuously stirred for 5 hr (Equations (1) and (2) in Figure 5). The precipitated KCl was filtered off and solvent was evaporated through rotary evaporator under reduced pressure. The product obtained was recrystallized from methanol and petroleum ether (2 : 1).

3. Results and Discussion

The complexes are solid having sharp melting points and are soluble in common organic solvents. The physical data is given in Table 1.

Table 1: Physical data of organotin complexes 1–5.

Comp. number
Molecular formula
Mol. Wt
Yield (%)
m.p (°C)
Elemental analysis Calcd. (found)

%C
%H
%N

HL
C₆H₁₁NO₂
129.16
—
300
—
—
—

1
C₈H₁₆NO₂SnCl
312.38
84
220
30.73 (30.77)
5.12 (5.16)
4.48 (4.44)

2
C₁₄H₂₈NO₂SnCl
396.54
84
233
42.36 (42.41)
7.06 (7.02)
3.53 (3.57)

3
C₁₈H₂₀NO₂SnCl
436.52
82
272
49.48 (49.52)
4.58 (4.62)
3.20 (3.24)

4
C₉H₁₉NO₂Sn
291.96
85
261
36.99 (36.95)
6.50 (6.54)
4.79 (4.83)

5
C₂₄H₂₅NO₂Sn
478.17
81
245
60.22 (60.26)
5.22 (5.26)
2.92 (2.96)

3.1. IR Spectroscopy

Infrared spectra of the organotin(IV) complexes provide valuable information regarding the structure of compounds and coordination geometry of the metal in the solid state. Infrared spectra were recorded as KBr/CsBr disc in the range of 4000–250 cm⁻¹ and the important bands are given in Table 2. The peculiar feature of the IR spectra of the complexes is the absence of νOH stretching vibration of the free carboxylic acid at 3639 cm⁻¹ due to deprotonation for coordination with tin(IV).

Table 2: IR dataa (cm⁻¹) of organotin(IV) complexes 1–5.

Comp. number
OH
NH
COO

Sn–C
Sn–O
Sn–Cl

asym
sym

HL
3639 b
3456b
1671w
1398s
273
—
—
—

1
—
3459m
1622s
1438s
184
543b
450m
375s

2
—
3457b
1629s
1483m
146
519w
449w
328s

3
—
3461b
1606s
1452w
154
279s
442b
318b

4
—
3462b
1601s
1441w
161
554s
451m
—

5
—
3456b
1551s
1370m
181
264s
447m
—

s: strong; m: medium; w: weak; b: broad.

IR spectroscopy supported the noninvolvement of amino nitrogen of the ligand HL with tin because vibrational frequency of νNH was not shifted to a considerable extent in complexes 1–5 as compared to the free ligand HL; these findings were further verified by ¹H and ¹³C NMR spectroscopy. The mode of tin carboxylate interaction was predicted from value; in the complexes lie in the range of 154–184 cm⁻¹ suggesting bidentate binding mode of the carboxylate group [25, 26]. Bidentate mode owes to the donation of electron density from C=O group to the tin. Bands for Sn-C vibration of organotin moieties were observed in the range 519–554 cm⁻¹ [complexes 1–3] and in the range 264–279 cm⁻¹ [complexes 4 and 5]. The appearance of new bands in the range 442–451 cm⁻¹ and 318–375 cm⁻¹ was assigned to Sn–O and Sn–Cl bond formation which further confirms complexation.

3.2. ¹H NMR Spectroscopy

The ¹H NMR data is given in Table 3. The signals were assigned by their distinct multiplicity patterns, resonance intensities, coupling constants, and tin satellites. The number of protons found by integration of peaks in the spectra agreed well with those calculated from the expected composition.

Table 3: 1H NMR dataa of organotin complexes 1–5.

Proton number
Chemical shift (ppm)

HL
1
2
3
4
5

1
2.32–2.41m
2.74–2.81m
2.90–2.96m
2.61–2.65m
2.36–2.43m
2.73–2.81m

2, (a)
1.83–1.89m
1.82–1.98m
1.86–1.90m
1.85–1.93m
1.78–1.88m
1.80–1.97m

2, (e)
2.12–2.17m
2.11–2.19m
2.11–2.18m
2.12–2.17m
2.05–2.11m
2.08–2.21m

3, (a)
2.74–2.79m
3.05–3.13m
2.88–2.92m
3.07–3.12m
2.97–3.05m
3.01–3.13m

3, (e)
3.23–3.35m
3.36–3.41m
3.15–3.22m
3.35–3.38m
3.32–3.35m
3.35–3.43m

4
2.50s
2.58s
2.52s
2.57s
2.59s
2.58s

Sn–R

0.78s 90
1.19–1.37m
—
0.4s 52
—

—
1.59–1.61m
7.85–7.89m
—
7.81–7.88m

—
1.40–1.56m
7.35–7.49m
—
7.42–7.52m

—
0.89t (7.2)
7.51–7.59m
—
7.50–7.62m

 ¹¹⁹Sn, ¹H and (¹H, ¹H) are listed in square brackets and parenthesis, respectively; multiplicity is given as s: singlet, t: triplet, and m: multiplet.

See Scheme 1.

Scheme 1

The absence of signal for carboxylic (–COOH) proton at 11.6 ppm of the free ligand in the spectra of complexes verified the coordination through deprotonated carboxylate anions. The amino proton of the free ligand HL does not show significant shift in the complexes 1–5, demonstrating the noninvolvement in coordination with tin and supporting the IR findings. The chemical shifts were assigned to the protons of alkyl- or aryltin moieties in complexes according to literature [27].

Table 4 represents the coupling constants () obtained from resolved satellites and the calculated C−Sn−C bond angles (θ) in solution state of di- and trimethyltin(IV) derivatives. The data strongly supports five and four coordinated geometry around tin [28]. Despite the complex pattern of di-n-butyl fragments in the spectrum of complex 2, a clear triplet due to terminal methyl group appeared at 0.89 ppm with (¹H, ¹H) = 7.2 Hz [15]. Ortho protons absorbed downfield as compared to meta and para protons in phenyltin(IV) derivatives [16]. ¹H NMR data for the phenyltin(IV) derivatives 3 and 5 described the existence of ortho (β) protons in the range 7.81–7.89 ppm as multiplet, while a multiplet in the range of 7.35–7.52 ppm and 7.50–7.62 ppm was assigned to meta (γ) and para (δ) protons, respectively. The ²J[¹¹⁹Sn, ¹H] values for complexes 1 and 4 are 90 and 52 Hz, respectively [16]. As far as the piperidine ring of the ligand is concerned, resonances for equatorial protons was assigned downfield as compared to the corresponding axial ones, according to literature [17].

Table 4: (C–Sn–C) angles (°) based on NMR parameters.

Comp. number
2J(¹¹⁹Sn, ¹H) (Hz)
Angle,

1
90.0
135.5

4
52
109.2

3.3. ¹³C NMR Spectroscopy

The ¹³C NMR spectra of the complexes 1–5 were recorded in deuterated DMSO and the resonances were assigned by comparison with the results obtained from incremental method [29]. The ¹³C NMR data is given in Table 5. The carboxylate carbon exhibited downfield chemical shift in the range 179.1–179.8 ppm in complexes 1–5. The resonance in the range 42.1–42.8 ppm was assigned to carbon atom (labeled as 2) present in the nearest neighborhood of carboxylate group, while signals at 27.2–27.9 ppm and 51.2–51.8 ppm were allocated for the carbon atoms labeled as 3,3′ and 4,4′, respectively. Dimethyltin(IV) moiety demonstrated chemical shift at 24.6 ppm in complex 1 while complex 2 exhibited signals at 25.7, 27.7, 26.2, and 14.2 for α, β, γ, and δ, carbon atoms, respectively, for butyl fragments.

Table 5: 13C NMR dataa of organotin complexes 1–5.

Carbon number
Chemical shift (ppm)

HL
1
2
3
4
5

1
178.2
179.5
179.1
179.6
179.8
179.7

2
42.6
42.1
42.8
42.4
42.6
42.8

3,
24.2
27.3
27.7
27.2
27.9
27.2

4,
51.1
51.3
51.6
51.5
51.8
51.2

Sn–R

—
24.6 593.1, 567.3
25.7 541.1, 516.3
135.2 56.4
−2.0 395.6
138.06 583.1, 557.3

—
—
27.7 39.0
141.2

128.99 61.4, 59.0

—
—
26.2 117.3, 112.6
129.1 88.2

136.57 44.3

—
—
14.2
130.2 56.6

129.94 12.5

Chemical shifts () in ppm. 119/117Sn, ¹³C in Hz is listed in square brackets.

See Scheme 1.

3.4. Mass Spectrometry

The electron ionization mass spectra (EI-MS) were recorded for complexes 2, 3, and 5. The data is given in Table 6. Molecular ion peak was only observed in complex 5 and was not displayed in the mass spectra of organotin(IV) derivatives 2 and 3 [30]. Complex 2 is primarily dissociated into chlorodibutytin ( (3%)) fragment and the deprotonated carboxylate ligand ( (3%)) or the primary fragmentation may eliminate two butyl radicals and one HCl molecule to produce [C₆H₉NO₂Sn]⁺ ion ( (9%)); the fragmentation is terminated with the appearance of butyl ions ( (100%)) as a base peak. The primary fragmentation in complex 3 occurs by the loss of a phenoxide ion showing a signal for M-93 ion or it may split the parent molecule into the deprotonated carboxylate ligand at (14%) and the chlorodiphenyltin(IV) moiety at (1%) thus strongly supporting the chlorodiorganotin(IV) product. The fragmentation is terminated with the decomposition of phenyl group to prouce C₄H₃ cation at m/z 51 (56%). In triphenyltin(IV) derivative 5, two peaks with (26%) and (30%) correspond to the molecular ion (M⁺) and M+1 ions, respectively. There are two modes of fragmentation; the dissociation may proceed via the loss of phenyl radicals step by step to yield the deprotonated carboxylate ligand, [C₁₂H₁₀Sn]⁺ ( (100%)) which then lose an oxygen atom to form [C₆H₁₀NO]⁺ ion ( (23%)) as end product or it may go ahead by the loss of a ligand fragment [] to yield triphenyltin cation [C₁₈H₁₅Sn]⁺ ( (77%)) which is finally degraded into [Sn]⁺ ion ( (1%)) after successive removal of the phenyl radical in three steps.

Table 6: Mass spectral data of organotin complexes 2, 3, and 5.

Comp. number
(%)

2
C₁₄H₂₈NO₂SnCl⁺ 397 (n.o)#, C₈H₁₈ClSn⁺ 269 (3), C₆H₉NO₂Sn⁺ 247 (9), C₄H₉ClSn⁺ 212 (8), C₄H₉Sn⁺ 177 (2), HO₂Sn⁺ 153 (12), C₆H₁₀NO₂⁺ 128 (3), Sn⁺ 120 (2), C₅H₈N⁺ 82 (3), C₄H₉⁺ 57 (100).

3
C₁₈H₂₀NO₂SnCl⁺ 437 (n.o)#, C₁₂H₁₅ClNOSn⁺ 344 (1), C₁₂H₁₀ClSn⁺ 309 (1), C₆H₁₀ClNOSn⁺ 267 (3), C₆H₈ClNOSn⁺ 265 (2), C₆H₅ClSn⁺ 232 (3), C₆H₅Sn⁺ 197 (3), C₁₂H₁₀⁺ 154 (9), C₆H₁₀NO₂⁺ 128 (14), C₆H₁₀NO⁺ 112 (3), C₆H₆⁺ 78 (100), C₆H₅⁺ 77 (35), C₃HN⁺ 51 (56).

5
C₂₄H₂₅NO₂Sn⁺ 479 (26)#, C₂₄H₂₅NO₂Sn⁺ 480 (30), C₁₈H₂₀NO₂Sn⁺ 402 (3), C₁₈H₁₅Sn⁺ 351 (77), C₁₂H₁₅NO₂Sn⁺ 325 (1), C₁₂H₁₀Sn⁺ 274 (1), C₆H₅Sn⁺ 197 (1), C₁₂H₁₀Sn⁺ 128 (100), Sn⁺ 120 (1), C₆H₁₀NO⁺ 112 (23).

Molecular ion peak (M⁺); n.o: not observed.

3.5. Semiempirical Study

In complexes 1–4, the ligand binds in bidentate fashion to the Sn(IV) atom. The three-organic groups/two organic groups, one Cl group, and the ligand are arranged in distorted trigonal bipyramidal geometry. One of the Sn–O bond lengths is shorter than the other and is consistent with literature [15]. The Sn–C and Sn–Cl bond lengths are close to reported values [15]. The O–Sn–O and C–Sn–C bond angles are also consistent with earlier reported structures [15]. All other bond lengths and angles (Table 7) are also comparable to literature values [15].

Table 7: Computed structural parameters of complexes 1–4.

Comp. number
1
2
3
4

Sn–O bond lengths (Å)
2.02, 2.61
2.02, 2.66
2.00, 2.65
2.03, 2.73

Sn–C bond lengths (Å)
2.08, 2.08
2.12, 2.13
2.05, 2.05
2.10, 2.10, 2.11

Sn–Cl bond length (Å)
2.36
2.37
2.35
—

O–Sn–O (°)
51.8
50.9
51.1
49.3

C–Sn–C (°)
119.3
115.6
114.6
109.9, 109.9, 114.2

Computed negative heats of formation indicate that all complexes are thermodynamically stable (Table 8). The calculated HOMO and LUMO orbitals of complexes 1–4 are shown in Figures 1, 2, 3, and 4. Notice in all the complexes without exception that the HOMO orbitals are localized on the piperidine ring, while the LUMO orbitals are localized on tin, carboxylates oxygens, and carbon atoms bonded to tin. The calculated HOMO and LUMO energies are given in Table 9. Though semiempirical method overestimates the HOMO and LUMO energies, the trends in variations are noteworthy. Substitution of an alkyl/aryl group in the organotin moieties by a chloride group lowers both the HOMO and LUMO energies in all the mono chlorosubstituted complexes. This lowering is more for LUMO than for HOMO, the overall effect being that the HOMO-LUMO gap is lower in the mono chlorosubstituted complexes. is associated with the ability of the molecule to donate electrons, (−Ionization Potential), and in this respect all the complexes have comparable electron donating abilities, (the effect of Me/Cl/Bu/Ph substituent is small). A comparison of values shows that, in each case, the alkyl/aryl organotin complexes are predicted to have a slightly higher electron donating ability than the mono chlorosubstituted one. on the other hand reflects the ability of a molecule to accept electrons (−Electron Affinity), and LUMO energy of the mono chlorosubstituted organotin moieties is nearly three-four times lower than that of the unsubstituted ones. This indicates that mono chlorosubstituted complexes have a better ability to accept electrons and are reflected by their higher electrophilicity values () [31] in each case (Table 9). A comparison of global hardness () values [32] (Table 9) shows that alkyl/aryl substituted complexes are harder than the mono chlorosubstituted tin compounds. A similar conclusion can be drawn from a comparison of global softness values () [33] (Table 9). A comparison of the chemical potential values (Table 9) [34] shows that the presence of electron donating alkyl/aryl groups increases the chemical potential and vice versa.

Table 8: Computed thermodynamic parameters (at 298 K) of complexes 1–4.

Comp. number
1
2
3
4

Heat of formation (KCal/mole)
−137.453
−161.812
−65.424
−109.346

Enthalpy (KCal/mole-K)
9.308
11.340
11.000
9.608

Entropy (KCal/mole-K)
0.117
0.130
0.128
0.118

Heat capacity (Cp) (Cal/mole-K)
54.555
72.716
71.764
57.727

Table 9: Computed molecular descriptors of complexes 1–4.

Comp. number
1
2
3
4

HOMO energy (eV)
−9.582
−9.527
−9.510
−9.408

LUMO energy (eV)
−1.483
−1.524
−1.556
−0.387

HOMO-LUMO (eV)
8.099
8.003
7.954
9.021

Dipole moment (debye)
3.282
4.509
4.477
1.668

Global hardness (, eV)
4.049
4.001
3.977
4.510

Global softness (, eV⁻¹)
0.123
0.124
0.125
0.110

Chemical potential (, eV)
−5.532
−5.525
−5.533
−4.897

Electophilicity ()
3.77
3.81
3.84
2.65

(a)

(b)

Figure 1: (a) HOMO of complex 1; (b) LUMO of complex 1.

(a)

(b)

Figure 2: (a) HOMO of complex 2; (b) LUMO of complex 2.

(a)

(b)

Figure 3: (a) HOMO of complex 3; (b) LUMO of complex 3.

(a)

(b)

Figure 4: (a) HOMO of complex 4; (b) LUMO of complex 4.

Figure 5

3.6. Antimicrobial Activity

The ligand HL and complexes 1–5 were screened to check their in vitro response against various strains of bacteria (Escherichia coli, Bacillus subtilis, Staphylococcus aureus, and Pasteurella multocida) and fungi (Alternaria alternata, Ganoderma lucidum, Penicillium notatum, Trichoderma harzianum, and Aspergillus niger). The data is given in Tables 10 and 11. It was found that the organotin(IV) complexes possessed significantly higher activity towards the tested organisms than the free ligands as reported earlier [12, 14, 35]. The coordination of the ligand with chlorodi- or triorganotin(IV) moieties has appreciably enhanced the activities of the product complexes. A close relationship was observed between structure and activity of the synthesized complexes; biological (antibacterial/antifungal) activities of the organotin(IV) complexes 1–5 were varied according to their substitution pattern at tin. The inhibitory action of organotin(IV) compounds is mainly due to their ability to interact with DNA and protein. The MIC data (Tables 12 and 13) also supports that the complexes displayed strong growth inhibitory effect against all microbes in contrast to the biologically inactive ligand [36].

Table 10: Antibacterial activity dataa, b of organotin complexes 1–5.

Comp. number
Bacterial inhibition zone (mm)

E. coli
B. subtilis
S. aureus
P. multocida

HL
—
—
—
—

1
30a  ±  0.14
20bc  ±  0.07
30ab  ±  0.28
22b  ±  0.20

2
26ab  ±  0.22
25ab  ±  0.19
30ab  ±  0.21
28ab  ±  0.31

3
28ab  ±  0.30
20bc  ±  0.14
30ab  ±  0.29
27ab  ±  0.14

4
14c  ±  0.12
14c  ±  0.15
16c  ±  0.20
15c  ±  0.11

5
21bc  ±  0.13
19bc  ±  0.07
23bc  ±  0.12
25ab  ±  0.22

Streptomycin
30a  ±  0.17
31a  ±  0.28
31ab  ±  0.31
29a  ±  0.28

Data are expressed as the mean ± standard deviation of samples analyzed individually in triplicate at .

bIt refers that how does bacterial inhibition zones are being calculated.

Table 11: Antifungal activity dataa, b of organotin complexes 1–5.

Comp. number
Fungal inhibition zone (mm)

A. alternata
G. lucidum
P. notatum
T. harzianum
A. niger

HL
—
—
—
—
—

1
14c  ±  0.15
21c  ±  0.20
14c  ±  0.11
13c  ±  0.07
25c  ±  0.23

2
20bc  ±  0.19
22bc  ±  0.13
19bc  ±  0.08
18c  ±  0.15
26bc  ±  0.23

3
22bc  ±  0.20
24bc  ±  0.14
28bc  ±  0.14
21ab  ±  0.18
26bc  ±  0.21

4
18bc  ±  0.11
23bc  ±  0.19
17bc  ±  0.07
17bc  ±  0.12
26bc  ±  0.15

5
25bc  ±  0.23
25bc  ±  0.21
28bc  ±  0.12
23a  ±  0.20
28bc  ±  0.23

Fluconazole
38a  ±  0.29
41a  ±  0.21
45a  ±  0.31
—
37a  ±  0.23

Data are expressed as the mean ± standard deviation of samples analyzed individually in triplicate at .

bIt refers that how does fungal inhibition zones are being calculated.

Table 12: MIC (bacterial) of organotin complexes 1–5.

Comp. number
Minimum inhibitory concentration (g/well)

E. coli
B. subtilis
S. aureus
P. multocida

HL
—
—
—
—

1
50
25
25
—

2
12.5
1.56
7.81 10⁻¹
7.81 10⁻¹

3
12.5
25
12.5
50

4
50
—
50
—

5
12.5
12.5
12.5
12.5

Streptomycin
9.7 10⁻²
1.95 10⁻¹
6.25
3.12

Table 13: MIC (fungal) of organotin complexes 1–5.

Comp. number
Minimum inhibitory concentration (g/well)

A. alternata
G. lucidum
P. notatum
T. harzianum
A. niger

HL
—
—
—
—
—

1
—
6.25
25
7.81 10⁻¹
3.12

2
1.56
7.81 10⁻¹
7.81 10⁻¹
3.90 10⁻¹
7.81 10⁻¹

3
7.81 10⁻¹
1.95 10⁻¹
1.95 10⁻¹
9.76 10⁻²
3.12

4
12.5
3.12
12.5
7.81 10⁻¹
3.12

5
9.76 10⁻²
3.12
2.44 10⁻²
2.44 10⁻²
3.90 10⁻¹

Fluconazole
1.56
1.56
2.44 10⁻²
25
—

3.7. Hemolytic Activity

Hemolytic activity was studied because, even if a synthesized compound possesses potent antimicrobial activities, its use in medicine will be impossible in the presence of hemolytic effects. Thus, in vitro hemolytic bioassays of the synthesized complexes was carried out with human red blood cells and the average lysis was observed with respect to the triton X-100 as positive control (100% lysis) and PBS as negative control (0% lysis). The results are given in Table 14.

Table 14: Hemolytic activity of organotin complexes 1–5.

Comp. number
% of hemolysis

HL
8.70 ± 0.03

1
26.85 ± 0.05

2
14.42 ± 0.05

3
10.58 ± 0.08

4
24.02 ± 0.03

5
20.93 ± 0.06

Triton X-100
99.53 ± 0.00

The lowest activity (10.58%) was observed for complex 3; however, this activity was found comparatively higher than free ligand HL. The highest value (26.85%) was recorded for the dimethyltin(IV) complex 1. However, it is worth mentioning that all the synthesized complexes possessed hemolytic activity which is very much lower as compared to triton X-100 and higher than PBS.

4. Conclusion

FTIR data indicates the bidentate chelating mode of carboxylate group which is confirmed by semiempirical study. NMR data shows 5- and 4-coordinated geometry in solution state. The EI-MS fragmentation patterns agreed well with the molecular structures of the complexes. HOMO-LUMO calculations show that chlorodiorganotin complexes are more susceptible to nucleophilic attack as compared to triorganotin complexes. Computed negative heat of formation indicates that complexes 1–4 are thermodynamically stable and chemically inert. The complexes exhibited significant antimicrobial activities. The hemolytic activity of complexes shows that the complexes exhibit comparatively higher hemolytic activity as compared to the free ligand.

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.

Acknowledgment

Shabbir Hussain thanks the HEC, Islamabad, Pakistan, for financial support under the Ph.D. Fellowship Scheme Batch-IV (PIN Code: 074-3160-Ps4-362).

References

E. R. T. Tiekink, “The rich diversity in tin carboxylate structures,” Trends Organometallic Chemistry, vol. 1, pp. 71–116, 1994.

S. Hussain, S. Ali, S. Shahzadi, and C. Rizzoli, “Polymeric three-dimensional crystal structure of a tributyltin(IV) derivative with acetylene dicarboxylic acid,” Phosphorus, Sulfur and Silicon and the Related Elements, vol. 188, no. 6, pp. 812–818, 2013.

C. J. Evans and S. Karpel, Organotin Compounds in Modern Technology, Elsevier Science, Amsterdam, The Netherlands, 1985.

F. W. van der Weij, “The action of tin compounds in condensation-type RTV silicone rubbers,” Macromolecular Chemistry and Physics, vol. 181, no. 12, pp. 2541–2548, 1980.

A. A. Mahmoud, A. F. Shaaban, M. M. Azab, and N. N. Messiha, “Organotin polymers-XVI. Synthesis of p-acryloyloxybenzoic acid and n-methacryloyloxytetrabromophthalimide and copolymerizations with tri-n-butyltin acrylate and methacrylate,” European Polymer Journal, vol. 28, no. 5, pp. 555–559, 1992.

R. Gachter and H. Muller, Plastics Additives Handbook, Hanser, Munich, Germany, 1990.

L. Pellerito and L. Nagy, “Organotin(IV)n+ complexes formed with biologically active ligands: equilibrium and structural studies, and some biological aspects,” Coordination Chemistry Reviews, vol. 224, no. 1-2, pp. 111–150, 2002.

S.-U. Rehman, K. Shahid, S. Ali, M. H. Bhatti, and M. Parvez, “Organotin esterification of (E)-3-(3-fluoro-phenyl)-2-(4-chlorophenyl)-2- propenoic acid: synthesis, spectroscopic characterization and in vitro biological activities. Crystal structure of [Ph₃Sn(OC(O)C(4-ClC₆H₄) = CH(3-FC₆H₄))],” Journal of Organometallic Chemistry, vol. 690, no. 5, pp. 1396–1408, 2005.

G. Arena, R. Calì, A. Contino, A. Musumeci, S. Musumeci, and R. Purrello, “Coordination properties of dialkyltin (IV) in aqueous solution. Thermodynamic study of dimethyltin (IV) complexes with l-amino acids,” Inorganica Chimica Acta, vol. 237, no. 1-2, pp. 187–191, 1995.

M. Gielen, “Organotin compounds and their therapeutic potential: A report from the Organometallic Chemistry Department of the Free University of Brussels,” Applied Organometallic Chemistry, vol. 16, no. 9, pp. 481–494, 2002.

S. Shahzadi, S. Ali, and M. Fettouhi, “Synthesis, spectroscopy, in vitro biological activity and X-ray structure of (4-methylpiperidine-dithiocarbamato-S,S′)triphenyltin(IV),” Journal of Chemical Crystallography, vol. 38, no. 4, pp. 273–278, 2008.

N. Muhammad, A. Shah, S. Shuja et al., “Organotin(IV) 4-nitrophenylethanoates: synthesis, structural characteristics and intercalative mode of interaction with DNA,” Journal of Organometallic Chemistry, vol. 694, no. 21, pp. 3431–3437, 2009.

W. N. Aldridge and J. J. Zuckerman, Organotin Compounds: New Chemistry and Applications. Advanced Chemistry, American Chemical Society, Washington, DC, USA, 1976.

M. Hussain, M. Hanif, M. Altaf, S. Ali, and K. J. Cavell, “Structural studies of diethyltin(IV) derivatives and their biological aspects as potential antitumor agents against Agrobacterium tumefacien cells,” Applied Organometallic Chemistry, vol. 25, no. 6, pp. 412–419, 2011.

S. Shahzadi and S. Ali, “Structural chemistry of organotin(IV) complexes,” Journal of the Iranian Chemical Society, vol. 5, no. 1, pp. 16–28, 2008.

S. Hussain, S. Ali, S. Shahzadi, S. K. Sharma, K. Qanungo, and I. H. Bukhari, “Homobimetallic complexes containing Sn(IV) with acetylene dicarboxylic acid: their syntheses and structural interpretation by spectroscopic, semi-empirical, and DFT techniques,” Journal of Coordination Chemistry, vol. 65, no. 2, pp. 278–285, 2012.

S. Hussain, S. Ali, S. Shahzadi et al., “Synthesis, characterization, and semi-empirical study of organotin(IV) complexes with 4-(hydroxymethyl)piperidine-1-carbodithioic acid: X-ray structure of chlorodimethyl-(4-hydroxymethyl piperidine-1-carbodithioato-S,S')tin(IV),” Phosphorus, Sulfur and Silicon and the Related Elements, vol. 186, no. 3, pp. 542–551, 2011.

W. L. F. Armarego and C. L. L. Chai, Purification of Laboratory Chemicals, Butterworth-Heinemann, London, UK, 5th edition, 2003.

J. J. P. Stewart, MOPAC, Stewart Computational Chemistry, Version 7.334W, 2007

J. J. P. Stewart, “H, C, N, O, Cl (PM3), optimization of parameters for semi-empirical methods II. Applications,” Journal of Computational Chemistry, vol. 10, pp. 209–220, 1989.

J. J. P. Stewart, “Optimization of parameters for semiempirical methods. III Extension of PM3 to Be, Mg, Zn, Ga, Ge, As, Se, Cd, In, Sn, Sb, Te, Hg, Tl, Pb, and Bi,” Journal of the Computational Chemistry, vol. 12, no. 3, pp. 320–341, 1991.

T. R. Fritsche, P. F. McDermott, T. R. Shryock, and R. D. Walker, “Agar dilution and disk diffusion susceptibility testing of Campylobacter spp,” Journal of Clinical Microbiology, vol. 45, no. 8, pp. 2758–2759, 2007.

S. D. Sarker, L. Nahar, and Y. Kumarasamy, “Microtitre plate-based antibacterial assay incorporating resazurin as an indicator of cell growth, and its application in the in vitro antibacterial screening of phytochemicals,” Methods, vol. 42, no. 4, pp. 321–324, 2007.

P. Sharma and J. D. Sharma, “In vitro hemolysis of human erythrocytes by plant extracts with antiplasmodial activity,” Journal of Ethnopharmacology, vol. 74, no. 3, pp. 239–243, 2001.

G. Huang, S. J. Moore, and D. Dehui, “Antioxidative and antibacterial activity of the methanol extract of Artemisia anomala,” African Journal of Biotechnology, vol. 7, no. 9, pp. 1335–1338, 2008.

T. S. Basu Baul, S. Dhar, N. Kharbani, S. M. Pyke, R. Butcher, and F. E. Smith, “The synthesis and structural characterization of some triorganotin (IV) complexes of 5-(4-chlorophenylazo) salicylic acid: crystal and molecular structure of triphenyltin 5-(4-chlorophenylazo) salicylate,” Main Group Metal Chemistry, vol. 22, no. 7, pp. 413–422, 1999.

G. Eng, X. Song, A. Zapata, A. C. de Dios, L. Casabianca, and R. D. Pike, “Synthesis, structural and larvicidal studies of some triorganotin 2-(p-chlorophenyl)-3-methylbutyrates,” Journal of Organometallic Chemistry, vol. 692, no. 6, pp. 1398–1404, 2007.

A. Saxena and J. P. Tandon, “Structural features of some organotin(IV) complexes of semi- and thio-semicarbazones,” Polyhedron, vol. 3, no. 6, pp. 681–688, 1984.

T. P. Lockhart, W. F. Manders, and E. M. Holt, “Solution and solid-state molecular structures of Me₂Sn(OAc)₂ (I) and its hydrolyzate, ([Me₂Sn(OAc)]₂O)₂ (II), by solution and solid-state 13C NMR. X-ray diffraction study of II,” Journal of the American Chemical Society, vol. 108, no. 21, pp. 6611–6616, 1986.

O. Kalinowski, S. Berger, and S. Braun, Carbon NMR Spectroscopy, John Wiley & Sons, Chichester, UK, 1988.

A. Meriem, R. Willem, J. Meunier-Piret, M. Biesemans, B. Mahieu, and M. Gielen, “Synthesis spectroscopic characterization and antitumour activity of diorgano tinbis(ortho-aminobenzoates) and some n-substituted derivatives thereof. Preliminary X-ray structure determination of di-n-butyltins(ortho-aminobenzoate),” Main Group Metal Chemistry, vol. 13, pp. 167–180, 1990.

R. G. Parr, L. V. Szentpály, and S. Liu, “Electrophilicity index,” Journal of the American Chemical Society, vol. 121, no. 9, pp. 1922–1924, 1999.

R. G. Parr and R. G. Pearson, “Absolute hardness: companion parameter to absolute electronegativity,” Journal of the American Chemical Society, vol. 105, no. 26, pp. 7512–7516, 1983.

W. Yang and R. G. Parr, “Hardness, softness, and the fukui function in the electronic theory of metals and catalysis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 82, no. 20, pp. 6723–6726, 1985.

R. G. Parr, R. A. Donnelly, M. Levy, and W. E. Palke, “Electronegativity: the density functional viewpoint,” The Journal of Chemical Physics, vol. 68, no. 8, pp. 3801–3807, 1977.

S. Shahzadi, S. Ali, M. H. Bhatti, M. Fettouhi, and M. Athar, “Chloro-diorganotin(IV) complexes of 4-methyl-1-piperidine carbodithioic acid: synthesis, X-ray crystal structures, spectral properties and antimicrobial studies,” Journal of Organometallic Chemistry, vol. 691, no. 8, pp. 1797–1802, 2006.